Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2012

View Archived Issues

Research at Merck Frosst Canada yields new HIV protease inhibitors

Merck KGaA discloses new PI3K inhibitors

Long-term results with Lenti-D reported

Takeda reviews achievements of fiscal 2011

Researchers describe preclinical and phase I results with AQX-1125

Cardioprotection observed with novel bivalent engineered neuregulin 1B protein

Secretin relieves pain in chronic pancreatitis patients

Novel Anacor Pharmaceuticals compound reduces inflammation in vivo

DPT-NX7 induces regressions in squamous cell carcinoma model

Lupin designs new CRAC channel modulators

Novel Abeta production inhibitors created at Dainippon Sumitomo

FDA includes 156-week data in new Isentress labeling

Canadian universities develop novel antibiotics

Kinex out-licenses rights to KX-02 in greater China territory

Peregrine Pharmaceuticals reports data from phase IIb study in NSCLC

New iPierian programs target Tau protein and complement pathway

Oxford BioTherapeutics presents new diagnostic antibodies

Daiichi Sankyo and the Japanese National Cancer Center enter anticancer collaboration

Achillion reports new proof-of-concept data for ACH-2684

CHDI Foundation to conduct preclinical research on Lundbeck compound

Cerecor commences exploratory trial of FP-01

Phase III MISSION trial misses primary endpoint

Third phase III trial of Sativex in cancer pain begins

Medivation submits NDA for enzalutamide

Enrollment complete in phase I trial of MOR-208

Phase IIb trial of Catalyst's treatment candidate for cocaine addiction reaches target enrollment

Cellceutix gives update on IND for novel p53 anticancer drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...